Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
15 août 2023 09h00 HE
|
Elevar Therapeutics
FORT LEE, N.J., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...